Stem cells and gliomas: past, present, and future

Area of Science:

• Neuro-oncology
• Stem Cell Biology
• Cancer Research

Background:

• Stem cells (SC) are present in the adult central nervous system (CNS).
• SC are associated with gliomas, leading to the study of glioma stem cells (GSC).
• High-grade gliomas (HGG) have a poor prognosis, necessitating novel therapeutic strategies.

Purpose of the Study:

• To provide a historical overview of SC and GSC discovery.
• To detail the current understanding of GSC, including markers, clinical significance, and therapeutic targeting.
• To explore the use of SC as delivery vehicles for HGG therapies.

Main Methods:

• Literature review of SC and GSC research.
• Analysis of current data on GSC characteristics and therapeutic strategies.
• Discussion of stem cell-based drug delivery systems for HGG.

Main Results:

• The discovery of SC and GSC has significantly advanced neuro-oncology research.
• GSC possess distinct markers and play a crucial role in HGG pathobiology.
• SC show potential as vectors for targeted therapeutic agent delivery to HGG.

Conclusions:

• Further research into GSC biology and targeting is essential for improving HGG treatment.
• Stem cell-based therapies hold promise for reducing tumor recurrence and enhancing patient survival.
• Future developments may lead to innovative strategies for managing high-grade gliomas.